Julie Gralow: Looking forward to participating in this US Pharmacopeia and American Cancer Society Cancer Action Network (ACS CAN) led dialogue on cancer drug shortages.

Julie Gralow, the Chief Medical Officer at the American Society of Clinical Oncology (ASCO), shared a post by US Pharmacopeia on LinkedIn:

“Looking forward to participating in this US Pharmacopeia and American Cancer Society Cancer Action Network (ACS CAN) led dialogue on cancer drug shortages. Sept 26 – see below link to register.”

Quoting US Pharmacopeia’s post:

“Please join the American Cancer Society (ACS), American Cancer Society Cancer Action Network (ACS CAN), and the USP Convention for a timely and impactful discussion with key thought leaders and experts on the pharmaceutical supply chain. Add your voice and perspective as we identify the most impactful interventions for policymakers, regulators, industry, healthcare, and providers to address the urgent issue of cancer drug shortages on behalf of patients nationwide.

When: Tuesday, September 26th, 2023, 9:00-11:00 ET

Please register for this virtual event and share this invitation with colleagues who would benefit from and contribute to this important dialogue.”

Source: Julie Gralow/LinkedIn

Julie Gralow is the Chief Medical Officer (CMO) and Executive Vice President of the American Society of Clinical Oncology (ASCO). Previously, she was the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington School of Medicine, Professor in the Clinical Research Division of the Fred Hutchinson Cancer Research Center, as well as Director of Breast Medical Oncology at the Seattle Cancer Care Alliance. She is the founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN). Dr. Gralow received the ASCO Humanitarian Award in 2018 for her work in empowering women cancer patients and survivors globally.